COMBINATION THERAPY FOR TREATING ALZHEIMER'S DISEASE

Details for Australian Patent Application No. 2002340201 (hide)

Owner MERCK AND CO. INC.

Inventors MACNEIL, Douglas, J.; ROSENBLUM, Charles, I.

Pub. Number AU-A-2002340201

PCT Number PCT/US02/32790

PCT Pub. Number WO2003/039542

Priority 60/330,158 17.10.01 US

Filing date 11 October 2002

Wipo publication date 19 May 2003

International Classifications

A61K 031/42 - Oxazoles

A61K 031/50 - Pyridazines

A61K 031/196

A61K 031/216

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/351 - not condensed with another ring

A61K 031/405

A61K 031/415 - 1,2-Diazoles

A61K 031/421 - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 031/505 - Pyrimidines

A61K 031/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/330,158 17.10.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002340201

1 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340202-Methods for the treatment of hyperpigmentation of skin

2002340200-Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists